A Long Term Study of GK530G in Subjects With Acne Vulgaris
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This open label study is to determine the safety profile of GK530G in a long-term treatment
(up to 12 months) in subjects with acne vulgaris and to evaluate the efficacy of GK530G in a
long-term treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Galderma R&D
Treatments:
Adapalene Adapalene, Benzoyl Peroxide Drug Combination Benzoyl Peroxide